Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$40.4 - $59.1 $15,756 - $23,049
-390 Reduced 0.98%
39,390 $1.6 Million
Q1 2023

May 10, 2023

SELL
$38.16 - $48.86 $118,906 - $152,247
-3,116 Reduced 7.26%
39,780 $1.93 Million
Q4 2022

Feb 09, 2023

BUY
$33.53 - $54.79 $215,430 - $352,025
6,425 Added 17.62%
42,896 $1.64 Million
Q3 2022

Nov 14, 2022

SELL
$41.85 - $53.85 $75,581 - $97,253
-1,806 Reduced 4.72%
36,471 $1.83 Million
Q2 2022

Aug 11, 2022

BUY
$25.6 - $45.23 $136,985 - $242,025
5,351 Added 16.25%
38,277 $1.68 Million
Q1 2022

May 04, 2022

SELL
$33.33 - $44.6 $3.68 Million - $4.92 Million
-110,418 Reduced 77.03%
32,926 $1.23 Million
Q4 2021

Feb 10, 2022

SELL
$35.36 - $41.86 $261,911 - $310,057
-7,407 Reduced 4.91%
143,344 $5.71 Million
Q3 2021

Nov 12, 2021

BUY
$37.01 - $44.74 $828,949 - $1 Million
22,398 Added 17.45%
150,751 $5.61 Million
Q2 2021

Aug 13, 2021

SELL
$37.95 - $49.37 $261,855 - $340,653
-6,900 Reduced 5.1%
128,353 $5.43 Million
Q1 2021

May 11, 2021

BUY
$46.8 - $68.92 $968,759 - $1.43 Million
20,700 Added 18.07%
135,253 $6.4 Million
Q4 2020

Feb 12, 2021

BUY
$47.96 - $67.64 $992,772 - $1.4 Million
20,700 Added 22.06%
114,553 $6.99 Million
Q3 2020

Nov 12, 2020

BUY
$45.41 - $57.07 $1.27 Million - $1.6 Million
28,038 Added 42.6%
93,853 $4.59 Million
Q2 2020

Aug 12, 2020

BUY
$42.56 - $54.98 $242,506 - $313,276
5,698 Added 9.48%
65,815 $3.34 Million
Q1 2020

May 13, 2020

BUY
$32.37 - $59.36 $306,932 - $562,851
9,482 Added 18.73%
60,117 $2.68 Million
Q4 2019

Feb 11, 2020

BUY
$32.22 - $50.07 $908,281 - $1.41 Million
28,190 Added 125.6%
50,635 $2.43 Million
Q3 2019

Nov 12, 2019

BUY
$33.82 - $48.17 $759,089 - $1.08 Million
22,445 New
22,445 $759,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Motley Fool Asset Management LLC Portfolio

Follow Motley Fool Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.